Clinnova Consortium Agreement Officially Signed Across All Partner Countries
Clinnova Consortium has officially signed its international Consortium Agreement across all participating partner countries, marking a major milestone in the development of one of Europe’s most ambitious cross-border initiatives in data-driven healthcare and chronic disease research.
Bringing together partners across Luxembourg, Switzerland, France, and Germany, the agreement formally establishes the collaborative framework behind Clinnova’s growing ecosystem of universities, university hospitals, research centres, digital health platforms, and clinical infrastructures. United by a shared vision, the consortium is working to transform how chronic inflammatory diseases are understood, studied, and ultimately treated through more connected, interoperable, and patient-centered healthcare systems.
At the heart of Clinnova is the ambition to securely connect fragmented clinical and research data across institutions and countries while respecting local governance and data protection standards. By enabling the harmonisation and analysis of high-quality multimodal datasets, the consortium is laying the foundations for a new generation of precision medicine, smarter prevention strategies, and more efficient cross-border healthcare innovation.
A key pillar of the initiative is the advancement of federated data analysis and interoperable research infrastructures, allowing institutions to collaborate on data-driven research without sensitive health data ever needing to leave local environments. This approach closely aligns with the vision of the European Health Data Space (EHDS), the European Union’s flagship initiative designed to enable secure, interoperable, and patient-centered health data exchange across Europe.
Through its federated learning approach, interoperable infrastructure, and cross-border governance model, Clinnova is already positioning itself as an EHDS-ready ecosystem and a real-world operational example of how international healthcare data collaboration can function at scale. Rather than simply discussing the future of connected healthcare, the consortium has been actively building the infrastructure, workflows, and partnerships needed to make it possible in practice.
“The signature of this agreement represents far more than a formal milestone,” said Ulf Nehrbass, CEO of Luxembourg Institute of Health (LIH).
It reflects a shared European ambition to build healthcare infrastructures that are interoperable, scalable, and capable of transforming how we generate knowledge from health data. What makes Clinnova particularly unique is its ability to bring together scientific excellence, technological innovation, and cross-border collaboration in a way that can create real impact for patients and healthcare systems alike.
The newly signed agreement also establishes the consortium’s governance framework, bringing together international leadership teams, scientific stakeholders, and local use-and-access committees to coordinate activities across participating countries and institutions.
Behind this milestone lies years of coordination across different healthcare systems, legal frameworks, funding structures, research environments, and institutional priorities. Aligning such a broad and multidisciplinary consortium required not only scientific leadership, but also operational alignment and long-term commitment from all partners involved.
“From an operational perspective, bringing a consortium of this scale to signature required years of coordination, alignment, and sustained commitment across countries, institutions, and disciplines,” said Jasmin Schulz, Strategic Programme Lead at LIH, who played a central role in coordinating the international consortium agreement across all partner institutions.
Building interoperable infrastructures across multiple healthcare and research environments is inherently complex. What made this possible was the collective trust between partners, the willingness to move beyond institutional boundaries, and a shared long-term vision for the future of collaborative healthcare innovation in Europe.
Clinnova spans expertise across clinical neurology, gastroenterology, rheumatology, biomedical research, digital health, bioinformatics, biobanking, and data science, creating a uniquely interdisciplinary environment designed to accelerate translational research and improve patient outcomes across chronic inflammatory diseases.
This milestone now sets the stage for the consortium’s next phase: scaling interoperable infrastructures, advancing federated analytics, strengthening cross-border clinical research, and generating meaningful insights from multimodal health data that can directly support clinicians, researchers, and ultimately patients.
As Europe moves toward a more connected and data-enabled healthcare future, Clinnova stands as a concrete example of what international collaboration can achieve when scientific ambition, technological innovation, and institutional alignment come together.
The official signing of the Consortium Agreement marks not the end of a process, but the beginning of a new chapter for collaborative healthcare innovation in Europe.